SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
620.00    9.00 (1.47%)
Bid:
621.00
Ask:
623.00
Spread: 2.00 (0.322%)
Market Cap: £540.17m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Trading Statement

9 Apr 2015 07:00

RNS Number : 6595J
Victrex PLC
09 April 2015
 



 

 

 

 

 

9 April 2015

Victrex plc

Half year and pre-close trading update

'A good first half; well positioned for full year progress'

Victrex plc, an innovative world leader in high performance polymer solutions, today releases its half year and pre-close trading update for the six months ended 31 March 2015.

Overall, Victrex delivered a good first half performance. Group revenue of £130.3m was 9% ahead of the prior year (H1 2014: £119.9m), with Group sales volume of 2,028 tonnes 28% ahead of the prior year (H1 2014: 1,584 tonnes). The first half performance reflects a continuing positive contribution from Consumer Electronics and slightly lower sales in our Invibio medical business. Group gross margins saw improvement compared to the first half of 2014, reflecting better manufacturing efficiencies.

In Victrex Polymer Solutions (VPS), lower sales into oil and gas were offset by growth in our other markets. Commissioning of the first production stream on our third PEEK manufacturing plant is now complete and successfully started up on schedule. In Invibio, performance reflected the impact from industry consolidation in the US during Q1, as previously communicated, although we saw an improvement in Q2. Invibio revenue of £25.9m was 4% down on the prior year (H1 2014: £26.9m) and flat in constant currency, although our focus remains on continued improvement as we enter the second half.

The adverse currency impact seen by the Group during the first half will also continue into the second half. However, as previously communicated, we continue to expect that we will fully overcome the currency impact for the full year.

David Hummel, Chief Executive of Victrex, said: "Victrex delivered a good first half performance overall. Although we are mindful of the tougher comparatives for the second half and the continued caution in the oil and gas market, we remain well positioned for progress over the full year."

Victrex will report its interim results on Tuesday 19 May 2015.

Enquiries:

Victrex plc:

Andrew Hanson, Head of Investor Relations & Communications +44 (0) 1253 898121

Louisa Burdett, Group Finance Director +44 (0) 1253 897700

David Hummel, Chief Executive +44 (0) 1253 897700

 

Pendomer Communications:

Charles Armitstead +44 (0) 203 603 5220

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of Automotive, Aerospace, Energy, Electronics and Medical. Every day, millions of people rely on products or applications which contain our materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 35 years' experience, we are investing in technical excellence to deliver new and leading edge solutions to our customers and our markets, and to drive value for our shareholders. Find out more at www.victrexplc.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGUCPCUPAGAR
Date   Source Headline
8th Feb 20117:00 amRNSAGM and Interim Management Statement
31st Jan 20114:36 pmRNSTotal Voting Rights
19th Jan 20112:33 pmRNSDirector/PDMR Shareholding
13th Jan 201111:59 amRNSHolding(s) in Company
10th Jan 20117:00 amRNSBoard Change
4th Jan 20113:30 pmRNSAnnual Information Update
4th Jan 20113:21 pmRNSTotal Voting Rights
22nd Dec 201012:43 pmRNSAnnual Financial Report
14th Dec 20103:09 pmRNSDirector/PDMR Shareholding
10th Dec 201012:04 pmRNSDirector/PDMR Shareholding
9th Dec 20109:27 amRNSHolding(s) in Company
8th Dec 20104:16 pmRNSDirector/PDMR Shareholding
8th Dec 201010:00 amRNSHolding(s) in Company
7th Dec 20107:00 amRNSFinal Results
1st Dec 201010:58 amRNSBlocklisting Interim Review
30th Nov 20102:54 pmRNSTotal Voting Rights
17th Nov 20104:07 pmRNSDirector/PDMR Shareholding
16th Nov 20103:38 pmRNSDirector Declaration
1st Nov 20102:11 pmRNSTotal Voting Rights
20th Oct 20102:11 pmRNSDirector/PDMR Shareholding
20th Oct 20102:11 pmRNSDirector/PDMR Shareholding
7th Oct 20107:00 amRNSAnnual Trading Update
1st Oct 20102:01 pmRNSTotal Voting Rights
17th Sep 20101:24 pmRNSDirector/PDMR Shareholding
15th Sep 201012:13 pmRNSHolding(s) in Company
31st Aug 201012:16 pmRNSTotal Voting Rights
17th Aug 20101:05 pmRNSDirector/PDMR Shareholding
5th Aug 20107:00 amRNSInterim Management Statement
5th Aug 20107:00 amRNSBoard Change
3rd Aug 201010:47 amRNSDirector Declaration
28th Jul 201012:53 pmRNSHolding(s) in Company
19th Jul 20102:48 pmRNSDirector/PDMR Shareholding
2nd Jul 20101:06 pmRNSDirector Declaration
30th Jun 20102:46 pmRNSTotal Voting Rights
22nd Jun 201011:06 amRNSDirector/PDMR Shareholding
18th Jun 201012:07 pmRNSDirector/PDMR Shareholding
7th Jun 20101:48 pmRNSDirector/PDMR Shareholding
2nd Jun 20102:37 pmRNSDirector/PDMR Shareholding
2nd Jun 201010:15 amRNSBlocklisting Interim Review
1st Jun 20103:49 pmRNSTotal Voting Rights
1st Jun 20103:34 pmRNSDirector/PDMR Shareholding
25th May 20107:00 amRNSHalf Yearly Report
18th May 20104:28 pmRNSDirector/PDMR Shareholding
30th Apr 201011:58 amRNSTotal Voting Rights
23rd Apr 201010:53 amRNSDirector Declaration
19th Apr 20102:52 pmRNSDirector/PDMR Shareholding
19th Apr 201011:41 amRNSHolding(s) in Company
12th Apr 20103:52 pmRNSHolding(s) in Company
9th Apr 20101:43 pmRNSHolding(s) in Company
8th Apr 20107:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.